加载中
NYSEHealthcareMedical - Distribution
最新数据
US$0.428
−US$0.0152 · -3.43%
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
前收盘价
US$0.428
−US$0.0152 · -3.43%
盘前
US$0.4292
+US$0.0012 · +0.28%
10月12日 7:55 ET
盘中时间采用ET。市场数据可能有所延迟。
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
日内区间
当前US$0.428
52周区间
当前US$0.428
盘中时间采用ET。市场数据可能有所延迟。
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
日内区间
当前US$0.428
52周区间
当前US$0.428
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 27.62亿 USD | 107.01亿 USD | 103.34亿 USD | 99.55亿 USD | 97.85亿 USD |
| 销货成本 | 14.73亿 USD | 84.82亿 USD | 82.09亿 USD | 81.29亿 USD | 82.72亿 USD |
| 毛利 | 12.89亿 USD | 22.19亿 USD | 21.25亿 USD | 18.26亿 USD | 15.13亿 USD |
| 研究与开发 | — | — | — | — | 1210万 USD |
| 销售、一般及管理费用 | 10.68亿 USD | 19.1亿 USD | 18.14亿 USD | 15.55亿 USD | 10.77亿 USD |
| 营业费用 | 10.68亿 USD | 24.27亿 USD | 20.21亿 USD | 16.83亿 USD | 11.45亿 USD |
| 利息支出 | 1.07亿 USD | 1.44亿 USD | 1.58亿 USD | 1.29亿 USD | 4809万 USD |
| 折旧和摊销 | 2.15亿 USD | 2.65亿 USD | 2.87亿 USD | 2.29亿 USD | 9062.1万 USD |
| 营业利润 | 2.22亿 USD | −2.08亿 USD | 1.05亿 USD | 1.43亿 USD | 3.68亿 USD |
| 净利润 | −11.01亿 USD | −3.63亿 USD | −4130.1万 USD | 2238.9万 USD | 2.22亿 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI264.5万0.00%2.3万亿 USD0.03%US$381.94+0.63%
Vanguard U.S. Value Factor ETFVFVA145.96万0.17%9.57亿 USD0.13%US$153.78-0.36%
Vanguard Extended Market ETFVXF100.83万0.00%954亿 USD0.05%US$235+0.80%
iShares Russell 2000 ETFIWM89.54万0.00%787.4亿 USD0.19%US$278.94+0.49%
Schwab Fundamental U.S. Small Company Index ETFFNDA55.88万0.01%87.82亿 USD0.25%US$35.62+0.17%
Vanguard Russell 2000 ETFVTWO49.98万0.00%180亿 USD0.06%US$112.66+0.50%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV23.46万0.00%268.09亿 USD0.33%US$37.95-0.39%
Dimensional - US Targeted Value ETFDFAT23.04万0.00%301.22亿 USD0.33%US$67.27-0.43%Vanguard Morningstar Total Stock Market ETFVTIVanguard U.S. Value Factor ETFVFVAVanguard Extended Market ETFVXFiShares Russell 2000 ETFIWMSchwab Fundamental U.S. Small Company Index ETFFNDAVanguard Russell 2000 ETFVTWOU.S. Small Cap Value Portfolio ETF Class SharesDFSVDimensional - US Targeted Value ETFDFATAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
